CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1111 - 1120 of 1139
Study Number Lead Group Study Title CIRB Study Status
S1300 SWOG A Randomized; Phase II Trial of Crizotinib Plus Pemetrexed Versus Pemetrexed Monotherapy in ALK-Positive Non-Squamous NSCLC Patients Who Have Progressed Systematically After Previous Clinical Benefit From Crizotinib Monotherapy<br> Adult CIRB - Early Phase Emphasis Completed
NCICOVID NCI NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study Adult CIRB - Late Phase Emphasis Completed
CALGB-10201 CALGB A Phase III Study of Daunorubicin and Cytarabine +\- G3139 (GenasenseTM; Oblimersen Sodium; NSC #683428; IND #58842); A BCL2 Antisense Oligodeoxynucleotide; in Previously Untreated Patients with Acute Myeloid Leukemia (AML) > 60 Years Adult CIRB - Late Phase Emphasis Completed
S0124 SWOG Randomized Phase III Trial of Cisplatin (NSC-119875) and Irinotecan (NCSC-616348) Versus Cisplatin and Etoposide (NSC-141540) in Patients With Extensive Stage Small Cell Lung Cancer (E-SCLC) Adult CIRB - Late Phase Emphasis Completed
S0334 SWOG Myeloma Specimen Repository Protocol Ancillary Adult CIRB - Late Phase Emphasis Completed
MDA2016-08-02 CP-CTNet_CLO-MD Anderson A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer Cancer Prevention and Control CIRB Completed
NRG-GU001 NRG Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer Adult CIRB - Late Phase Emphasis Completed
GOG-0198 GOG A Randomized Study of Tamoxifen Versus Thalidomide (NSC # 66847) in Patients with Biochemical-Recurrence-Only Epithelial Ovarian Cancer; Cancer of the Fallopian Tube; and Primary Peritoneal Carcinoma after First Line Chemotherapy Adult CIRB - Late Phase Emphasis Completed
ADVL0221 COG A Phase II Study of Trabectedin (ET-743; Yondelis) in Children with Recurrent Rhabdomyosarcoma; Ewing Sarcoma; or Nonrhabdomyosarcomatous Soft Tissue Sarcomas Pediatric CIRB Completed
MAY2016-07-01F CP-CTNet_CLO-Mayo Clinic Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Weekly Erlotinib for Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Completed
Displaying 1111 - 1120 of 1139